Innate Pharma S.A. (IPHA) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q4'22 | Q2'22 | Q4'21 | Q2'21 | Q4'20 | Q2'20 | Q4'19 | Q2'19 | Q4'18 | Q2'18 | Q4'17 | Q2'17 | Q4'16 | Q2'16 |
|---|
| Cash from Operations | -23.4M | -34.04M | -9.93M | 3.04M | -21.09M | -11.46M | -20.2M | 1.05M | -27.17M | -31.24M | 6.29M | -57.44M | -24.65M | 60.66M | 1.4M | -33.93M | -24.99M | -23.07M | -14.78M | -22.07M |
| Operating CF Margin % | 1128.59% | -700.35% | -3598.55% | 24.59% | -127.4% | -32.44% | -243.15% | 2.54% | -972.65% | -335.19% | 23.32% | -156.32% | -141.78% | 117.59% | 1.97% | -147.53% | -109.79% | -108.45% | -32.83% | -106.68% |
| Operating CF Growth % | -135.56% | -1221.11% | 52.91% | 126.48% | -4.41% | -1192.95% | 25.63% | 103.36% | -531.62% | 45.62% | 125.53% | -194.69% | -1863.23% | 278.8% | 105.59% | -47.05% | -69.02% | -4.55% | -111.14% | -110.58% |
| Net Income | -27.63M | -23.31M | -24.71M | -24.76M | -9.29M | 1.72M | -64.35M | 6.38M | -21.76M | -23.72M | -53.65M | -10.33M | -34M | 13.24M | 18.17M | -15.12M | -25.03M | -23.36M | 15.81M | -3.17M |
| Depreciation & Amortization | 671.99K | 772.17K | 852K | 1.14M | 1.45M | 3.65M | 2.38M | 2.04M | 2.38M | 2.19M | 6.56M | 6.72M | 9.7M | 6.83M | 4.9M | 2.44M | 2.27M | 2.13M | 1.7M | 1.56M |
| Stock-Based Compensation | 0 | 0 | 2.24M | 1.71M | 2.85M | 700.5K | 826.5K | 1.3M | 882K | 426.5K | 825.5K | 412K | 925.5K | 987.5K | 1.64M | 1.06M | 4.81M | 5.18M | 1.03M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | -15.91M | 5.74M | -28.58M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 936.05K | 3.98M | 3.83M | -6.36M | -3.06M | 16.91M | 36.72M | 30.89M | -14.21M | 13.29M | 58.12M | 38.47M | 20M | -78.5M | -68.48M | -13.64M | 50.39M | -15.12M | -28.77M | -16.73M |
| Working Capital Changes | 2.62M | -15.48M | 7.85M | 31.31M | -13.05M | -18.53M | -1.53M | -10.98M | 2.75M | -12.64M | 8.39M | -57.59M | -942K | 41.19M | 45.18M | -8.67M | -57.43M | 8.1M | -4.56M | -3.73M |
| Change in Receivables | 0 | -2.93M | -31.84M | 31.84M | -9.66M | -4M | 9.09M | -13.29M | -3.12M | 6.51M | 0 | -10.68M | 0 | 98.18M | 121.95M | -4.35M | -19.08M | 8.1M | -11.45M | -4.73M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | -4.33M | 0 | 0 | 54K | -3.92M | 2.24M | -9.91M | 11.55M | -12.49M | 0 | -10.59M | 0 | -6.62M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 752.31K | 7.62M | 8.27M | 932K | 20.88M | -246K | 2.3M | -420K | -951K | -333K | -1.47M | -12.87M | -544K | -62.87M | 9.52M | 14.76M | -27.86M | -1.6M | 31.32M | 29.19M |
| Capital Expenditures | -85.05K | -66.62K | -108K | -283K | -42K | -312K | -702K | -421K | -995K | -336K | -1.44M | -9.9M | -543K | -64.87M | -164K | -709K | -1.65M | -1.31M | -332K | -1.02M |
| CapEx % of Revenue | -4.1% | 1.37% | 39.13% | 2.29% | 0.25% | 0.88% | 8.45% | 1.02% | 35.62% | 3.61% | 5.33% | 26.95% | 3.12% | 125.74% | 0.23% | 3.08% | 7.25% | 6.18% | 0.74% | 4.92% |
| Acquisitions | 4.96K | 0 | 0 | 0 | 300K | 0 | 0 | 0 | 5K | 2K | -27K | 36K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -6.49M | -117.96K | -1.21M | 1.22M | 20.62M | 66K | 1.19M | 12.5K | 40K | -3.5K | -449.5K | -5.78M | -1K | 1K | 9.68M | 15.47M | -26.21M | -287K | 31.65M | 30.21M |
| Cash from Financing | -3.71M | 11.44M | -1.68M | -4.33M | -720K | -1.25M | -1.06M | -766K | 28.2M | -1.07M | 190K | -1.03M | 78.7M | -728K | 61.91M | -685K | 1.19M | -274K | -452K | -150K |
| Debt Issued (Net) | -4.7M | -4.87M | -8.94M | -4.42M | 0 | 0 | -1.07M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 989.95K | 16.31M | -186K | 186K | 94K | 0 | 0 | 192K | 0 | 61K | 0 | 3K | 0 | 1K | 0 | 0 | 0 | 900K | 104K | 310K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 7.44M | -93K | -814K | -1.25M | 6K | -958K | 28.2M | -1.13M | 190K | -1.03M | 78.7M | -729K | 61.91M | -1.26M | 1.19M | -1.33M | -556K | -460K |
| Net Change in Cash | -25.57M | -5.71M | -3.59M | 69.99M | -809K | -12.81M | -18.72M | -807K | -224K | -32.81M | 5.25M | -71.34M | 53.51M | -2.94M | 36.41M | -9.93M | -25.82M | -12.45M | 8.03M | 3.49M |
| Free Cash Flow | -23.48M | -34.1M | -10.04M | 2.75M | -21.14M | -11.78M | -20.91M | 628K | -28.16M | -31.57M | 4.86M | -67.34M | -25.19M | -4.21M | 1.23M | -34.64M | -26.64M | -24.39M | -15.12M | -23.09M |
| FCF Margin % | 1132.7% | -701.65% | -3637.68% | 22.3% | -127.65% | -33.32% | -251.59% | 1.52% | -1008.27% | -338.79% | 17.99% | -183.27% | -144.9% | -8.16% | 1.74% | -150.62% | -117.04% | -114.63% | -33.56% | -111.6% |
| FCF Growth % | -133.87% | -1338.66% | 52.5% | 123.38% | -1.1% | -1975.32% | 25.77% | 101.99% | -680.04% | 53.12% | 119.27% | -1500.33% | -2141.57% | 87.85% | 104.63% | -42.03% | -76.22% | -5.64% | -92.78% | -111.08% |
| FCF per Share | -0.26 | -0.39 | -0.12 | 0.03 | -0.26 | -0.14 | -0.26 | 0.01 | -0.35 | -0.40 | 0.06 | -0.85 | -0.38 | -0.06 | 0.02 | -0.60 | -0.49 | -0.45 | -0.27 | -0.43 |
| FCF Conversion (FCF/Net Income) | 0.85x | 1.59x | 0.40x | -0.12x | 2.27x | -6.67x | 0.31x | 0.17x | 0.93x | 1.32x | -0.12x | 5.56x | 0.73x | 4.58x | 0.08x | 2.24x | 1.00x | 0.99x | -0.94x | 6.96x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |